|
시장보고서
상품코드
2052396
세포 동결보존 시장 : 제품 유형별, 용도별, 최종사용자별, 지역별Cell Cryopreservation Market, By Product Type, By Application, By End User, By Geography |
||||||
세포 동결보존 시장은 2026년에 153억 5,000만 달러로 추정되며, 2033년까지 668억 9,000만 달러에 달할 것으로 전망됩니다. 2026년부터 2033년까지 CAGR 23.4%로 성장할 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 153억 5,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 23.40% | 2033년 시장 규모 예측: | 668억 9,000만 달러 |
세포 동결보존은 액체 질소를 이용해 보통 -80°C 이하의 극저온으로 냉각시켜 세포를 보존하는 기술입니다. 이를 통해 세포의 생존율을 손상시키지 않고 매우 오랜 기간 동안 세포를 보존할 수 있습니다. 암 및 유전성 질환의 유병률 증가, 재생의료 연구 투자 확대, 줄기세포은행, 불임치료, 조직공학 등의 요인으로 인해 연구기관 및 병원의 세포 동결보존 프로세스에 대한 수요가 증가할 것으로 예상됩니다. 또한, 냉동 보존 장치 및 솔루션의 기술 발전도 시장 성장을 촉진하는 요인으로 작용할 것입니다. 그러나 냉동 보존 절차 및 장비에 따른 높은 비용은 예측 기간 동안 시장 성장을 저해할 수 있습니다.
시장 역학
세계 세포 동결보존 시장의 성장은 주로 만성질환 및 생명을 위협하는 질병의 발생률 증가에 의해 주도되고 있습니다. 전 세계적으로 암과 유전성 질환의 유병률이 증가함에 따라 냉동 보존된 세포에 크게 의존하는 연구 활동, 세포 치료 및 임상시험에 대한 수요가 증가하고 있습니다. 세계암연구기금(WCRF)에 따르면, 2021년 전 세계적으로 약 1,800만 건의 신규 암 사례가 보고되었습니다. 또한, 재생의료, 줄기세포 연구 및 의료 바이오테크놀러지 혁신에 대한 민관의 투자 증가도 냉동보존 프로세스의 보급을 촉진하고 있습니다. 그러나 냉동 보존 장비, 액체 질소 및 전체 절차와 관련된 높은 비용이 시장 성장을 저해할 수 있습니다. 숙련된 전문 인력 부족과 서냉 공정의 기술적 문제도 시장 성장을 저해하는 요인으로 작용할 수 있습니다. 로봇에 의한 냉동보존 기술 및 장비의 지속적인 개발은 유망한 성장 기회를 가져올 수 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 조사는 다음과 같은 매개 변수를 기반으로 세계 세포 동결보존 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 이 세계 세포 동결보존 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가를 포함한 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 세포 동결보존 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 세포 동결보존 시장 : 제품 유형별, 2021-2033년
제5장 세계의 세포 동결보존 시장 : 용도별, 2021-2033년
제6장 세계의 세포 동결보존 시장 : 최종사용자별, 2021-2033년
제7장 세계의 세포 동결보존 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고문헌 및 조사 방법
KSM 26.06.16Cell Cryopreservation Market is estimated to be valued at USD 15.35 Bn in 2026 and is expected to reach USD 66.89 Bn by 2033, growing at a compound annual growth rate (CAGR) of 23.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 15.35 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 23.40% | 2033 Value Projection: | USD 66.89 Bn |
Cell cryopreservation involves preserving cells by cooling them to extremely low temperatures, usually -80°C or below using liquid nitrogen. It helps to preserve cells for a very long period of time without affecting their viability. Factors such as rising prevalence of cancers and genetic disorders, increasing investments in regenerative medicine research, stem cell banking, fertility preservation and tissue engineering can boost demand for cell cryopreservation processes across research institutes and hospitals. Technological advancements in cryopreservation equipment and solutions can also drive the market growth. However, high costs associated with cryopreservation procedures and equipment can hamper the market growth during the forecast period.
Market Dynamics
Global cell cryopreservation market growth is mainly driven by rising incidence of chronic and life-threatening diseases. Growing prevalence of cancers and genetic disorders globally boosts demand for research activities, cell therapies and clinical trials which heavily rely on cryopreserved cells. According to the World Cancer Research Fund, approximately 18 million new cancer cases were reported globally in 2021. Furthermore, increasing investments by both public and private players in regenerative medicine, stem cell research and medical biotech innovations have also boosted the uptake of cryopreservation processes. However, high costs associated with cryopreservation equipment, liquid nitrogen and overall procedures can hamper the market growth. Lack of skilled professionals and technical challenges during slow freezing processes can also hamper the market growth. Ongoing developments in robotic cryostorage technologies and equipment can offer lucrative market growth opportunities.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cell cryopreservation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare, Lonza Group Ltd., STEMCELL Technologies Inc., BioLife Solutions, Inc., Cryolife, Inc., Organ Recovery Systems Inc., Custom Biogenic Systems, Sartorius AG, Takara Bio Inc., Chart Industries, Inc., Biocision, LLC, Cardinal Health, Inc., Helmer Scientific
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global cell cryopreservation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell cryopreservation market
Market Segmentation
- By Product Type (Revenue, USD Bn, 2021 - 2033)
- Cryoprotectant Agents
- Glycerol
- Dimethyl Sulfoxide (DMSO)
- Others
- Equipment
- Incubators
- Liquid Nitrogen Supply Tanks
- Freezers
- Others
- By Application (Revenue, USD Bn, 2021 - 2033)
- Stem Cells
- Oocytes and Embryotic cells
- Sperm Cells
- Hepatocytes
- Others
- By End User (Revenue, USD Bn, 2021 - 2033)
- Biopharmaceutical & Pharmaceutical Companies
- Research Institutes
- Biobanks
- IVF clinics
- Others
- By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- Thermo Fisher Scientific Inc.
- Merck KGaA
- GE Healthcare
- Lonza Group Ltd.
- STEMCELL Technologies Inc.
- BioLife Solutions, Inc.
- Cryolife, Inc.
- Organ Recovery Systems Inc.
- Custom Biogenic Systems
- Sartorius AG
- Takara Bio Inc.
- Chart Industries, Inc.
- Biocision, LLC
- Cardinal Health, Inc.
- Helmer Scientific
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Cell Cryopreservation Market, By Product Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Cryoprotectant Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Glycerol
- Dimethyl Sulfoxide (DMSO)
- Others
- Equipment
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Incubators
- Liquid Nitrogen Supply Tanks
- Freezers
- Others
5. Global Cell Cryopreservation Market, By Application, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Stem Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Oocytes and Embryotic cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Sperm Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Hepatocytes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Cell Cryopreservation Market, By End User, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Biopharmaceutical & Pharmaceutical Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Biobanks
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- IVF clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Cell Cryopreservation Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lonza Group Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- STEMCELL Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BioLife Solutions, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cryolife, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Organ Recovery Systems Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Custom Biogenic Systems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sartorius AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Chart Industries, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biocision, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cardinal Health, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Helmer Scientific
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific Inc.
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
